ArticleBMC ophthalmology2025
A nomogram for identifying premyopia and myopia candidates in Chinese children: focusing on those with cycloplegic spherical equivalent refraction ≤ + 0.75D.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Myopia as a Global Public Health Challenge a Narrative Review.Life (Basel, Switzerland) · 2026Review
- Identifying and Managing Pre-Myopia: A Narrative Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPrimary refractive error screening parameters are commonly employed in clinical and community settings before cycloplegic assessment of myopia, however, their utility in identifying premyopia and myopia intervention candidates remains underexplored. This study aimed to develop a nomogram based on these routinely measured parameters to support clinical decision-making for premyopia and myopia prevention.
methodsPediatric patients (aged 4-17 years) from two medical centers in China were enrolled in this retrospective cohort study. A predictive model for the candidates of premyopia and myopia intervention was developed using logistic regression with multiple imputations. The model included the following primary screening parameters: age, gender, uncorrected visual acuity (UCVA), average corneal curvature (ACC), non-cycloplegic spherical equivalent refraction (NCSER), axial length (AL), and the axial length to average corneal radius of curvature (AL/ACRC) ratio. The efficacy of the model was assessed using the area under the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis (DCA). R was employed to conduct all statistical analyses.
resultsA total of 1006 participants (507 females, 499 boys) were enrolled, with 87.4% demonstrating cycloplegic spherical equivalent refraction (CSER) ≤ + 0.75D. In multivariate logistic regression, UCVA, NCSER, AL, and AL/ACRC were identified as independent predictors. These predictors were incorporated into a nomogram to predict the candidates for premyopia and myopia intervention. The nomogram exhibited exceptional discrimination in the derivation set (AUC = 0.971, 95% CI: 0.957-0.984), whereas in the external validation set, the AUC was 0.921 (95% CI: 0.866-0.976) when a cutoff of 0.851 in derivation set was employed. Calibration was verified through the calibration curve and Hosmer-Lemeshow tests (P = 0.99 and P = 0.96, respectively), and the decision curve analysis demonstrated robust clinical utility for threshold probabilities of 0.10-1.00 in the derivation set and 0.20-1.00 in the external validation set.
conclusionThe nomogram derived from the parameters of primary refractive error screening has the potential to preliminarily predict premyopia and myopia intervention candidates, thereby facilitating clinical decision-making in the context of premyopia and myopia prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.